Knoll Viprinex Compassionate Use Site Protocol Violations Cited By FDA
Executive Summary
Three of Knoll's Viprinex (ancrod) clinical trial sites were cited by FDA for inadequate monitoring and protocol violations during Oct. 15-30, 1998 inspections.